Probiotic Modulation of Immune Responses in Gastrointestinal Systems

Probiotics, defined as live microorganisms that confer a health benefit on the host when administered in adequate amounts, play a central role in shaping mucosal and systemic immunity. Within the gastrointestinal tract, these commensal bacteria reinforce the integrity of the epithelial barrier, regulate local and distal inflammatory pathways and contribute to homeostatic cross-talk between immune cells and the microbial community. Key probiotic genera such as Lactobacillus and Bifidobacterium exert their effects via multiple mechanisms: production of bioactive metabolites, interaction with pattern recognition receptors on innate immune cells, modulation of tight junction proteins and enhancement of regulatory T cell populations. These actions mitigate excessive pro-inflammatory responses, promote tolerance to harmless antigens and support the maturation of adaptive immunity. Clinically, probiotic interventions have been explored in inflammatory bowel disease, infectious diarrhoea, metabolic disorders and as adjuncts to vaccination, demonstrating global relevance for both prevention and therapy. Emerging omics technologies, including transcriptomics and metabolomics, have provided a systems-level view of probiotic–host interactions, revealing how specific bacterial strains influence gene expression programmes linked to cytokine production, barrier function and microbial ecology. As precision approaches evolve, strain selection, dosage optimisation and individual host factors will determine the future of probiotic modulation in gut-centred immunotherapy.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Probiotic Modulation of Immune Responses in Gastrointestinal Systems publication trend

The graph below shows the total number of articles in probiotic modulation of immune responses in gastrointestinal systems across all publications each year (not limited to Nature Index journals).

Technical terms

Probiotic: Live microorganism that, when administered in adequate amounts, confers a health benefit on the host.

Regulatory T cells (Tregs): A subset of CD4+ T lymphocytes that suppress immune activation and maintain tolerance to self and non-harmful antigens.

Cytokines: Small secreted proteins that mediate and regulate immunity, inflammation and haematopoiesis.

Pattern recognition receptors (PRRs): Innate immune receptors (for example Toll-like receptors) that detect conserved microbial molecules and initiate inflammatory signalling.

Tight junction proteins: Transmembrane and scaffolding proteins forming seal-like complexes between epithelial cells, critical for barrier function and regulation of paracellular permeability.

References

1. Bifidobacterium mechanisms of immune modulation and tolerance. Gut Microbes (2023).
2. Probiotics Mechanism of Action on Immune Cells and Beneficial Effects on Human Health. Cells (2023).
3. Deciphering Microbiome, Transcriptome, and Metabolic Interactions in the Presence of Probiotic Lactobacillus acidophilus against Salmonella Typhimurium in a Murine Model. Antibiotics (2024).